<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Congenital <z:e sem="disease" ids="C0242666" disease_type="Disease or Syndrome" abbrv="">protein S deficiency</z:e> is associated with an increased risk of <z:hpo ids='HP_0004936'>venous thrombosis</z:hpo> </plain></SENT>
<SENT sid="1" pm="."><plain>A14-year-old boy presented with <z:e sem="disease" ids="C0014544" disease_type="Disease or Syndrome" abbrv="">epileptic</z:e> <z:hpo ids='HP_0001250'>seizures</z:hpo> and <z:mp ids='MP_0005048'>thrombosis</z:mp> of the superior sagittal sinus and frontal hemorrhagic venous infarction after ingestion of 50 mg of dimenhydrinate, an <z:chebi fb="0" ids="50919">antiemetic</z:chebi> drug </plain></SENT>
<SENT sid="2" pm="."><plain>The patient was found to be heterozygous for the <z:e sem="disease" ids="C0584960" disease_type="Disease or Syndrome" abbrv="">factor V Leiden mutation</z:e> and had a functional <z:e sem="disease" ids="C0242666" disease_type="Disease or Syndrome" abbrv="">protein S deficiency</z:e> </plain></SENT>
<SENT sid="3" pm="."><plain>He recovered completely within a month after conservative treatment </plain></SENT>
<SENT sid="4" pm="."><plain>Dimenhydrinate may have disrupted a subclinical pre-existing condition in this case </plain></SENT>
</text></document>